Nature Publishing Group, publisher of Nature, and other science journals and reference works
Nature
my account e-alerts subscribe register
   
Sunday 22 November 2009
Journal Home
Current Issue
AOP
Archive
Download PDF
References
Export citation
Export references
Send to a friend
More articles like this

Letters to Nature
Nature 371, 528 - 531 (06 October 1994); doi:10.1038/371528a0

Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding

Riki Kurokawa*, James DiRenzo*, Marcus Boehm, Jeffrey Sugarman*, Berndt Glossparallel, Michael G. Rosenfeld§parallel, Richard A. Heyman & Christopher K. Glass*§£

* Division of Cellular and Molecular Medicine,§ Division of Endocrinology and Metabolism, parallel Howard Hughes Medical Institute, University of California, San Diego, 9500 Oilman Drive, La Jolla, California 92093-0656, USA
Department of Medicinal Chemistry, Department of Cell Biology, Ligand Pharmaceuticals,9393 Towne Center Drive, San Diego, California 92121, USA
£ To whom correspondence should be addressed

RETINOIC acid receptors (RARs) and retinoid X receptors (RXRs) regulate transcription by binding to response elements in target genes that generally consist of two direct repeat half-sites of consensus sequence AGGTCA (ref. 1). RAR/RXR heterodimers activate transcription in response to all-trans or 9-cis retinoic acid by binding to direct repeats spaced by five base pairs (DR5 elements)2–8, such that RAR occupies the downstream naif-site9–12. RXR homodimers activate transcription in response to 9-cis retinoic acid by binding to direct repeats spaced by one base pair (DR1 elements)8,13,14. Although RXR/RAR heterodimers bind to DR1 elements with higher affinity than RXR homodimers, in most contexts they are unable to activate transcription in response to either all-trans or 9-cis retinoic acid3–5. As a result, RARs inhibit RXR-dependent transcription from these sites13,15. We report that the switching of the RAR from an activator to an inhibitor of retinoid-dependent transcription requires that it be bound to the upstream half-site of DR1 elements and that it allosterically block the binding of ligand to the RXR.

------------------

References
1. Glass, C. K. Endocr. Rev. 15, 1503−1519 (1994).
2. Umesono, K., Murakami, K. K., Thompson, C. C. & Evans, R. M. Cell 65, 1255−1266 (1991). | Article | PubMed | ISI | ChemPort |
3. Yu, V. C. et al. Cell 67, 1251−1266 (1991). | Article | PubMed | ISI | ChemPort |
4. Kliewer, S. A., Umesono, K., Mangelsdorf, D. J. & Evans, R. M. Nature 355, 446−449 (1992). | Article | PubMed | ISI | ChemPort |
5. Leid, M. et al. Cell 68, 377−395 (1992). | Article | PubMed | ISI | ChemPort |
6. Zhang, X.-K., Hoffmann, B., Tran, P. B.-V., Graupner, G. & Pfahl, M. Nature 355, 441−446 (1992). | Article | PubMed | ISI | ChemPort |
7. Marks, M. S. et al. EMBO J. 11, 1419−1435 (1992). | PubMed | ISI | ChemPort |
8. Heymann, R. A. et al. Cell 68, 397−406 (1992). | Article | PubMed | ISI | ChemPort |
9. Kurokawa, R. et al. Genes Dev. 7, 1423−1435 (1993). | PubMed | ISI | ChemPort |
10. Perlmann, T., Rangarajan, P. N., Umesono, K. & Evans, R. M. Genes Dev. 7, 1411−1422 (1993). | PubMed | ISI | ChemPort |
11. Predki, P. F., Zamble, D., Sarkar, B. & Giguere, V. Molec. Endocr. 8, 31−39 (1993).
12. Zechel, C. et al. EMBO J. 13, 1425−1433 (1994). | PubMed | ISI | ChemPort |
13. Mangelsdorf, D. J. et al. Cell 66, 555−561 (1991). | Article | PubMed | ISI | ChemPort |
14. Levin, A. A. et al. Nature 355, 359−361 (1992). | Article | PubMed | ISI | ChemPort |
15. Lehmann, J. M. et al. Science 258, 1944−1946 (1992). | PubMed | ISI | ChemPort |
16. Mangelsdorf, D. J., Ong, E. S., Dyck, J. A. & Evans, R. M. Nature 345, 224−229 (1990). | Article | PubMed | ISI | ChemPort |
17. Umesono, K. & Evans, R. M. Cell 57, 1139−1146 (1989). | Article | PubMed | ISI | ChemPort |
18. Mader, S., Kumar, V., deVerneuil, H. & Chambon, P. Nature 338, 271−274 (1989). | Article | PubMed | ISI | ChemPort |
19. Danielsen, M., Hinck, L. & Ringold, G. M. Cell 57, 1131−1138 (1989). | Article | PubMed | ISI | ChemPort |
20. Willis, M. C., Hicke, B. J., Uhlenbeck, O. C., Cech, T. R. & Koch, T. H. Science 262, 1255−1257 (1993). | PubMed | ISI | ChemPort |
21. Wilson, T. E., Paulsen, R. E., Padgett, K. A. & Millbrandt, J. Science 256, 107−110 (1992). | PubMed | ISI | ChemPort |
22. Lee, M. S., Kliewer, S. A., Provencal, J., Wright, P. E. & Evans, R. M. Science 260, 1117−1121 (1993). | PubMed | ISI | ChemPort |
23. de The, H., Vivianco-Ruíz, M.d.M., Tiollais, P., Stunnenberg, H. & Dejean, A. Nature 343, 177−180 (1990). | Article | PubMed | ISI | ChemPort |
24. Sucov, H. M., Murakami, K. K. & Evans, R. M. Proc. natn. Acad. Sci. USA. 87, 5392−5396 (1990). | ChemPort |
25. Hoffmann, B. et al. Molec. Endocrinol. 4, 1727−1736 (1990). | ChemPort |
26. Glass, C. K., Holloway, J. M., Devary, O. V. & Rosenfeld, M. G. Cell 54, 313−323 (1988). | Article | PubMed | ISI | ChemPort |



© 1994 Nature Publishing Group
Privacy Policy